NewsRamp Health & Wellness Podcast

Forian Inc. sees revenue growth, Lixte Biotech advances precision oncology, Aptevo's mipletamig shows promising results in AML treatment, Ethema Health appoints new CFO, and Sigyn Therapeutics introduces CardioDialysis for cardiovascular disease. Exciting advancements in cancer immunotherapy are also highlighted.

Lantern Pharma's FDA-approved STAR-001 trial targets pediatric CNS cancer, Catalyst Crew Tech launches CardioAI for cardiovascular risk assessment, and RHON-KLINIKUM AG achieves solid financial results in 2025.

Soligenix obtains 10-year exclusivity in EU for Behcet Disease treatment, following positive Phase 2a data, enhancing its rare autoimmune condition focus.

Oragenics discloses audit opinion, Lexaria Bioscience adds 5 new patents, NeuroOne® completes successful limited release of nerve ablation system, and Okogen Inc. acquires intellectual property for ranpirnase to expand ophthalmic program.

HeartBeam collaborates with Mount Sinai to advance AI-ECG technology, proton therapy shows promising results in cancer treatment, Soligenix prepares for key clinical milestones, and Engle Services offers tips for AC breakdowns in Alabama.

VolitionRx shows promising results in early cancer detection, GeoVax Labs progresses towards Phase 3 trial, and AccuRoute and InterFAX offer secure healthcare solutions for regulated industries.

Notable developments include revenue reports, clinical trial data, AI advancements, and oncological breakthroughs, showcasing growth and progress in the health tech and biopharma sectors.

Lantern Pharma and American Shared Hospital Services to discuss financial results; breakthrough discovery supports CardioDialysis for neuroinflammatory diseases; Catalyst Crew Technologies expands into Venezuela for healthcare tech initiatives.

Viromed Medical AG secures funding for cold plasma technology, Soligenix advances rare disease therapies, LIXTE Biotechnology targets cancer treatment improvement, and orthodontic practices offer cutting-edge care.

Jodi Ungrodt, a seasoned financial leader and SEC-Qualified Financial Expert, brings valuable expertise to BioStem Technologies as the new Chair of the Audit Committee. Meanwhile, global tributes honor the legacy of martial arts legend Chuck Norris, highlighting his profound impact on performance and conditioning in the sports nutrition industry.